BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

Cytogen Pages on BioPortfolio:

BioPortfolio - Cytogen - Profile
Cytogen is a specialty pharmaceutical company dedicated to advancing the treatment and .... Genetic Engineering News: Oct 28 2009 6:24PM Matching:
cytogen ...
http://www.bioportfolio.com/biocorporate/3174-Cytogen.pdf...

BioPortfolio.com - BioWeb PROSTASCINT CAPROMAB PENDETIDE Search
site map contact us home SEARCH- ABOUT CYTOGEN PRODUCTS HEALT H CARE PROFESSIONAL Quadramet Information ProstaScint Information FAQs Clin ical
Pharmacology ...
http://www.bioportfolio.co.uk/PROSTASCINT+CAPROMAB+PENDETIDE...

BioPortfolio - Cytogen
Cytogen - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/3174-Cytogen.html...

BioPortfolio Biotechnology BioNews : live article
Cytogen Corporation (USA) IV-158. Cytomatrix LLC (USA) IV-162. CytRx Corporation (USA) IV-163. Dendreon Corporation (USA) IV-165. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

BioPortfolio - Dowpharm - Dowpharma and Cytogen Agree to Develop ...
to enable Cytogen to develop this novel cancer therapy," said Nick Hyde, ... William Goeckeler, Ph.D., senior vice president of operations at Cytogen. ...
http://www.bioportfolio.com/news/Dowpharma_and_Cytogen_Agree...

BioPortfolio.com - BioWeb CONDYLOX PODOFILOX Search
... Applicant: CYTOGEN CORP Active Ingredient(s): SAMARIUM SM 153 EDTMP OTC/RX Status: RX Indication(s): For relief of pain in patients with confirmed. ...
http://www.bioportfolio.co.uk/CONDYLOX+PODOFILOX-bioweb.htm...

BioPortfolio - Tamoxifen
Cytogen is a specialty pharmaceutical company dedicated to advancing the treatment and care of cancer patients by building, developing, and
commercializing ...
http://www.bioportfolio.com/indepth/Tamoxifen.html...

BioPortfolio.com - BioWeb ZENAPAX DACLIZUMAB Search
IU/mL Corixa Corp License 1614 Bexxar Tositumomab and Iodine I-131 Tositumomab 125011/0 6/27/2003 Therapeutic Regimen Cytogen Corp License 1164 ProstaScint ...
http://www.bioportfolio.co.uk/ZENAPAX+DACLIZUMAB-bioweb.htm...

Medical Imaging Markets Volume IV Contrast Agents
Cytogen Corp. Daiichi Pharmaceutical Co. Ltd. Dendritic NanoTechnologies Inc. Dowpharma Draximage Epix Pharmaceuticals Inc. E-Z-EM Inc. GE Healthcare ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_628.html...

BioPortfolio - Indium
Dowpharma and Cytogen Agree to Develop PSMA Antibody for Treatment of Cancer Agreement applies ChelaMed(sm) radiopharmaceutical services from Dowpharma(sm)
...
http://www.bioportfolio.com/indepth/Indium.html...

Results from other life science and pharmaceutical sites:

BioSpace - Cytogen Corporation News, Search Jobs, Events
16 Oct 2002 ... Cytogen Corporation is a biopharmaceutical company with an established and growing product line in prostate cancer and other areas of ...
http://www.biospace.com/company_profile.aspx?CompanyId=1356...

Cytogen Research & Development Inc.
Cytogen Research & Development Inc. 89 Bellevue Hill Rd. West Roxbury, MA 02132- 6423. Phone: 617-325-7774. Fax: 617-327-2405. View Product Categories.
http://www.biosupplynet.com/cfdocs/suppliers/supp_det.cfm?su...

Cytogen Corporation 22-Sep-99 - DETAIL
... Company Name, Issuing Office, Subject. 09/22/1999, Cytogen Corporation, Center for Biologics Evaluation and Research, OncoScint & ProstaScint ...
http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/1...

Cytogen Corporation Acquires North American Marketing Rights To ...
11 Oct 2006 ... Prescription product expands Cytogen's portfolio of supportive care products in oncology with oral agent to treat certain common side ...
http://www.biospace.com/news_story.aspx?NewsEntityId=32888...

Summary of CYTOGEN CORP - Yahoo! Finance
14 Mar 2008 ... Under the terms of the settlement agreement, Advanced Magnetics paid us $4 million and released 50000 shares of Cytogen common stock held in ...
http://biz.yahoo.com/e/080314/cyto10-k.html...

Cytogen Corporation Release: Prostate-Specific Membrane Antigen ...
PRINCETON, N.J., May 22 /PRNewswire-FirstCall/ -- Cytogen Corporation today announced the presentation of data demonstrating the expression of ...
http://www.biospace.com/news_story.aspx?NewsEntityId=19364...

Comparison of serum PSMA, PSA levels with results of Cytogen-356 ...
Comparison of serum PSMA, PSA levels with results of Cytogen-356 ProstaScint scanning in prostatic cancer patients. Murphy GP, Maguire RT, Rogers B, ...
http://www.ncbi.nlm.nih.gov/pubmed/9397201...

EUSA Pharma to Acquire US Specialty Oncology Company Cytogen ...
11 Mar 2008 ... Cytogen is a specialty pharmaceutical company with three oncology and pain control products on the American market, a specialist US sales ...
http://www.biospace.com/news_story.aspx?NewsEntityId=88816...

YAC/BAC FISH Mapping Resource (MCN Reference Center)
In collaboration with the Mendelian Cytogenetic Network (MCN, coordinator:N. Tommerup, Copenhagen http://www.mcndb.imbg.ku.dk) we develop a valuable tool ...
http://www.molgen.mpg.de/~cytogen/...

Cytogen Corporation Presents Phase 1 Data Showing Promising ...
28 Jun 2007 ... PRINCETON, N.J.--(BUSINESS WIRE)--Cytogen Corporation (NASDAQ: CYTO) reported updated data from a Phase 1 dose escalation study evaluating ...
http://www.biospace.com/news_story.aspx?NewsEntityId=61607...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.